Paras Biopharma Announces Industry leading Scale-up Development & Production Process of an "Onco-Immunology Fc-fusion"
Paras Biopharma extensive efforts have resulted in successful scale-up, optimization & development of a biologically-active onco-immunology, “peptide FC-fusion” OULU, FINLAND, July 12, 2023 /EINPresswire.com/ -- The scale-up of biologic products are …